INT MEDICAL (01501) released its interim results, with a profit attributable to shareholders of 110 million yuan, an increase of 11.97% year-on-year.
E-Thai Medical (01501) announced its interim results for the six months ended June 30, 2026. The group reported revenue of 596 million yuan, a year-on-year increase of 29.28%; the profit attributable to equity shareholders was 110 million yuan, reflecting an increase of 11.97% year-on-year; earnings per share were 0.54 yuan.
INT MEDICAL (01501) announced its interim results for the six months ending June 30, 2026, with revenue of 596 million yuan, an increase of 29.28% year-on-year; profit attributable to equity shareholders was 110 million yuan, an increase of 11.97% year-on-year; earnings per share were 0.54 yuan.
The announcement stated that the revenue increase was primarily due to acquisitions and mergers filling product gaps, establishing a complete product category matrix; as well as achieving synergies through channel reuse and supply chain integration, which in turn drove the growth in sales of interventional medical devices.
Related Articles
JIMU GROUP (08187) issued a profit warning, expecting a comprehensive net loss of approximately HKD 6.5 million for the first half of the year, an increase of about 66.7% year-on-year.
S.F. Holding (06936) plans to invest up to 305 million yuan to subscribe for shares in Fengchao, deepening its strategic layout in last-mile logistics.
SUN.KING TECH (00580) will distribute an interim dividend of HKD 0.01 per share on October 23.
JIMU GROUP (08187) issued a profit warning, expecting a comprehensive net loss of approximately HKD 6.5 million for the first half of the year, an increase of about 66.7% year-on-year.
S.F. Holding (06936) plans to invest up to 305 million yuan to subscribe for shares in Fengchao, deepening its strategic layout in last-mile logistics.
SUN.KING TECH (00580) will distribute an interim dividend of HKD 0.01 per share on October 23.
RECOMMEND
